Skip to content

Analysis of the Diagnostic Value of T1-Weighted Structural Imaging in DSC-PWI for Brain Tumors

Analysis of the Diagnostic Value of T1-Weighted Structural Imaging in DSC-PWI for Brain Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123206
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-22
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

The T1 structure is superimposed like the observation group.:None
The T1 structure without superposition is similar to the control group.:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, gender not restricted; 2. Intracranial space-occupying lesions were detected through clinical and imaging examinations, and surgical procedures were performed to obtain pathological diagnoses; 3. Standard MRI examinations were completed before the surgery, including: conventional plain scan sequences (T1WI, T2WI, FLAIR, etc.), T1 enhanced sequences, and dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI); 4. The quality of DSC-PWI images is good, with no obvious motion artifacts, and quantitative analysis can be conducted; 5. Complete clinical data and clear postoperative pathological results are available.

Exclusion criteria

Exclusion criteria: 1.Patients who have previously received intracranial tumor-related treatments (such as surgery, radiotherapy, chemotherapy, targeted therapy, or immunotherapy) that may affect perfusion parameters; 2.Patients with severe intracerebral hemorrhage, large-area necrosis, or obvious cystic changes that may affect accurate ROI delineation

Design outcomes

Primary

MeasureTime frame
Perfusion parameter measurement variability indicators;

Secondary

MeasureTime frame
Diagnostic performance metrics;

Countries

China

Contacts

Public ContactLiu Xiang

Yuebei People’s Hospital

liuxiangxl72@163.com+86 751 691 3416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026